Your hard-earned money would be better spent elsewhere.

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...

Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...

It’s become a trope in Silicon Valley to liken the rise of AI to t. Hardcore AI true-believers often say that the rise of ...

OpenAI has talked about how having an automated AI researcher was on its roadmap, and it’s shown the first glimpses of that ...

Self-improving models are reshaping the AI race as OpenAI, Anthropic, Google and others pursue superintelligence.

Magic: The Gathering’s new Marvel Super Heroes set is here, and as you can probably imagine, it’s absolutely packed with ...

ThreatsDay Bulletin covers fraud arrests, supply-chain attacks, phishing, cloud hijacking, ransomware, Windows flaws, and ...

News: DXC’s new Bengaluru centre reflects India’s expanding role in enterprise modernisation as AI, legacy systems and ...

The market trades near all-time highs with extreme valuations, driven by passive investing and questionable underlying ...

Background Adult-onset Still’s disease (AOSD) is a systemic autoinflammatory disorder lacking a gold-standard diagnostic ...